Secured convertible notes issued
Company: Core Scientific
The claim, verbatim
Core Scientific issued approximately $19.5 million in aggregate principal amount of secured convertible notes convertible into up to 3,346,958 shares of Common Stock
Source (primary)
Core Scientific SC 13D/A filed 2024-01-25 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “approximately $19.5 million in aggregate principal amount of secured convertible notes that may be convertible into up to 3,346,958 shares of Common Stock”
How we checked this
Checked on September 18, 2026. The cited source supports part of this claim, but not all of it.
The $19.5 million figure and the 3,346,958-share conversion figure describe only BlackRock's holding of the notes. The filing does not give the total amount Core Scientific issued.
Confirmed in the source:
- Core Scientific secured convertible notes were distributed under its reorganization plan on January 23, 2024
- BlackRock acquired approximately $19.5 million in aggregate principal amount of these notes, convertible into up to 3,346,958 shares of Common Stock
We could not confirm this from the cited source:
- That approximately $19.5 million (convertible into up to 3,346,958 shares) was the total amount of secured convertible notes Core Scientific issued
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524015411/d545166dsc13da.htm) in full (13,263 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-01-25
Quote: “approximately $19.5 million in aggregate principal amount of secured convertible notes that may be convertible into up to 3,346,958 shares of Common Stock”